한글목차

뚜렛 증후군 치료제 시장은 2024-2029년 7억 1,710만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 7.1%를 보일 것으로 예측됩니다.

뚜렛 증후군(Tourette's Syndrome) 치료제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 투렛 증후군에 대한 인식 증가, 전 세계적으로 투렛 증후군의 사례 증가, 비용 효율적인 치료법에 대한 수요 증가 등이 시장을 주도하고 있습니다.

이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

이 보고서는 투렛 증후군에 대한 R&D 투자 증가가 향후 몇 년 동안 투렛 증후군 치료제 시장의 성장을 가속하는 주요 이유 중 하나로 꼽고 있습니다. 또한, 시장 기업들 간의 전략적 제휴 증가와 헬스케어 인프라 지출 증가는 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망 2024년-2029년

제5장 시장 규모 실적

• 세계의 뚜렛 증후군 치료제 시장(2019-2023년)
• 제품별 부문 분석(2019-2023년)
• 유통 채널별 부문 분석(2019-2023년)
• 용도별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 세계의 뚜렛 증후군 치료제 시장

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제8장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 항정신병제 : 시장 규모와 예측(2024-2029년)
• 비항정신병제 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 제품별

제9장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 오프라인 : 시장 규모와 예측(2024-2029년)
• 온라인 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 유통 채널별

제10장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 어린이 : 시장 규모와 예측(2024-2029년)
• 성인 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 용도별

제11장 고객 상황

• 고객 상황 개요

제12장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 스페인 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제13장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제14장 경쟁 구도

• 개요
• 경쟁 구도
• 파괴적 혁신 상황
• 업계 리스크

제15장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Camber Pharmaceuticals Inc.
• Catalyst Pharmaceuticals Inc
• Eli Lilly and Co.
• Emalex Biosciences Inc.
• H Lundbeck AS
• Johnson and Johnson Services Inc.
• Neurocrine Biosciences Inc.
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Reviva Pharmaceuticals Holdings Inc
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.

제16장 부록

영문목차

The tourettes syndrome drugs market is forecasted to grow by USD 717.1 mn during 2024-2029, accelerating at a CAGR of 7.1% during the forecast period. The report on the tourettes syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness about tourette syndrome, increasing cases of tourette syndrome across world, and increasing demand for cost-effective treatments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's tourettes syndrome drugs market is segmented as below:

By Product

• Antipsychotics
• Non-antipsychotics

By Distribution Channel

• Offline
• Online

By Application

• Children
• Adults

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing research and development investments for tourette syndrome as one of the prime reasons driving the tourettes syndrome drugs market growth during the next few years. Also, rising strategic alliances among market companies and increasing healthcare infrastructure expenditure will lead to sizable demand in the market.

The report on the tourettes syndrome drugs market covers the following areas:

• Tourettes Syndrome Drugs Market sizing
• Tourettes Syndrome Drugs Market forecast
• Tourettes Syndrome Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tourettes syndrome drugs market vendors that include AstraZeneca Plc, Bausch Health Companies Inc., Camber Pharmaceuticals Inc., Catalyst Pharmaceuticals Inc, Eli Lilly and Co., Emalex Biosciences Inc., H Lundbeck AS, Johnson and Johnson Services Inc., Neurocrine Biosciences Inc., Novartis AG, Otsuka Holdings Co. Ltd., Reviva Pharmaceuticals Holdings Inc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Torrent Pharmaceuticals Ltd.. Also, the tourettes syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Tourettes Syndrome Drugs Market 2019 - 2023
  • Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.4 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global Tourettes syndrome drugs market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

• 8.1 Market segments
  • Chart on Product - Market share 2024-2029 (%)
  • Data Table on Product - Market share 2024-2029 (%)
• 8.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 8.3 Antipsychotics - Market size and forecast 2024-2029
  • Chart on Antipsychotics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Antipsychotics - Market size and forecast 2024-2029 ($ million)
  • Chart on Antipsychotics - Year-over-year growth 2024-2029 (%)
  • Data Table on Antipsychotics - Year-over-year growth 2024-2029 (%)
• 8.4 Non-antipsychotics - Market size and forecast 2024-2029
  • Chart on Non-antipsychotics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Non-antipsychotics - Market size and forecast 2024-2029 ($ million)
  • Chart on Non-antipsychotics - Year-over-year growth 2024-2029 (%)
  • Data Table on Non-antipsychotics - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Distribution Channel

• 9.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 9.3 Offline - Market size and forecast 2024-2029
  • Chart on Offline - Market size and forecast 2024-2029 ($ million)
  • Data Table on Offline - Market size and forecast 2024-2029 ($ million)
  • Chart on Offline - Year-over-year growth 2024-2029 (%)
  • Data Table on Offline - Year-over-year growth 2024-2029 (%)
• 9.4 Online - Market size and forecast 2024-2029
  • Chart on Online - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online - Market size and forecast 2024-2029 ($ million)
  • Chart on Online - Year-over-year growth 2024-2029 (%)
  • Data Table on Online - Year-over-year growth 2024-2029 (%)
• 9.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 10.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 10.3 Children - Market size and forecast 2024-2029
  • Chart on Children - Market size and forecast 2024-2029 ($ million)
  • Data Table on Children - Market size and forecast 2024-2029 ($ million)
  • Chart on Children - Year-over-year growth 2024-2029 (%)
  • Data Table on Children - Year-over-year growth 2024-2029 (%)
• 10.4 Adults - Market size and forecast 2024-2029
  • Chart on Adults - Market size and forecast 2024-2029 ($ million)
  • Data Table on Adults - Market size and forecast 2024-2029 ($ million)
  • Chart on Adults - Year-over-year growth 2024-2029 (%)
  • Data Table on Adults - Year-over-year growth 2024-2029 (%)
• 10.5 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.12 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.13 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.14 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.15 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.16 Spain - Market size and forecast 2024-2029
  • Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Data Table on Spain - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 15.5 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key news
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
  • SWOT
• 15.6 Camber Pharmaceuticals Inc.
  • Camber Pharmaceuticals Inc. - Overview
  • Camber Pharmaceuticals Inc. - Product / Service
  • Camber Pharmaceuticals Inc. - Key offerings
  • SWOT
• 15.7 Catalyst Pharmaceuticals Inc
  • Catalyst Pharmaceuticals Inc - Overview
  • Catalyst Pharmaceuticals Inc - Product / Service
  • Catalyst Pharmaceuticals Inc - Key offerings
  • SWOT
• 15.8 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 15.9 Emalex Biosciences Inc.
  • Emalex Biosciences Inc. - Overview
  • Emalex Biosciences Inc. - Product / Service
  • Emalex Biosciences Inc. - Key offerings
  • SWOT
• 15.10 H Lundbeck AS
  • H Lundbeck AS - Overview
  • H Lundbeck AS - Product / Service
  • H Lundbeck AS - Key offerings
  • SWOT
• 15.11 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
  • SWOT
• 15.12 Neurocrine Biosciences Inc.
  • Neurocrine Biosciences Inc. - Overview
  • Neurocrine Biosciences Inc. - Product / Service
  • Neurocrine Biosciences Inc. - Key offerings
  • SWOT
• 15.13 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.14 Otsuka Holdings Co. Ltd.
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key news
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Segment focus
  • SWOT
• 15.15 Reviva Pharmaceuticals Holdings Inc
  • Reviva Pharmaceuticals Holdings Inc - Overview
  • Reviva Pharmaceuticals Holdings Inc - Product / Service
  • Reviva Pharmaceuticals Holdings Inc - Key offerings
  • SWOT
• 15.16 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
• 15.17 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT
• 15.18 Torrent Pharmaceuticals Ltd.
  • Torrent Pharmaceuticals Ltd. - Overview
  • Torrent Pharmaceuticals Ltd. - Business segments
  • Torrent Pharmaceuticals Ltd. - Key offerings
  • Torrent Pharmaceuticals Ltd. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations